Profil
Takahiko Baba worked as an Executive Director at C&O Pharmaceutical Technology (Holdings) Ltd.
and as a General Manager-Overseas Business Division at Shionogi & Co., Ltd.
He obtained an undergraduate degree and a doctorate from Kyushu University.
Anciens postes connus de Takahiko Baba
| Sociétés | Poste | Fin |
|---|---|---|
| SHIONOGI & CO., LTD. | Corporate Officer/Principal | - |
C&O Pharmaceutical Technology (Holdings) Ltd.
 C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Directeur/Membre du Conseil | - |
Formation de Takahiko Baba
| Kyushu University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHIONOGI & CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Health Technology |